Concepts (409)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 44 | 2023 | 363 | 7.540 |
Why?
|
| Suprachiasmatic Nucleus | 25 | 2022 | 122 | 4.500 |
Why?
|
| Motor Activity | 16 | 2023 | 346 | 2.480 |
Why?
|
| Cricetinae | 54 | 2023 | 362 | 2.280 |
Why?
|
| Mesocricetus | 44 | 2023 | 92 | 1.790 |
Why?
|
| Photoperiod | 11 | 2015 | 30 | 1.710 |
Why?
|
| Light | 29 | 2015 | 195 | 1.670 |
Why?
|
| Mutation | 11 | 2023 | 2670 | 1.290 |
Why?
|
| Luteinizing Hormone | 25 | 2019 | 101 | 1.290 |
Why?
|
| Neurons | 10 | 2019 | 935 | 1.230 |
Why?
|
| Testis | 18 | 2015 | 160 | 1.030 |
Why?
|
| Melatonin | 24 | 1999 | 66 | 1.020 |
Why?
|
| Animals | 89 | 2023 | 21459 | 0.970 |
Why?
|
| Periodicity | 17 | 2013 | 46 | 0.960 |
Why?
|
| Cryptochromes | 3 | 2022 | 41 | 0.920 |
Why?
|
| Biological Clocks | 7 | 2015 | 59 | 0.880 |
Why?
|
| tau Proteins | 7 | 2019 | 212 | 0.870 |
Why?
|
| Animal Welfare | 2 | 2013 | 13 | 0.790 |
Why?
|
| Period Circadian Proteins | 7 | 2018 | 68 | 0.790 |
Why?
|
| Chronobiology Discipline | 2 | 2020 | 2 | 0.780 |
Why?
|
| Jet Lag Syndrome | 1 | 2022 | 4 | 0.750 |
Why?
|
| Sleep | 2 | 2013 | 245 | 0.630 |
Why?
|
| Heart Diseases | 2 | 2022 | 223 | 0.620 |
Why?
|
| Ovulation | 3 | 2019 | 28 | 0.620 |
Why?
|
| Pineal Gland | 19 | 2004 | 26 | 0.600 |
Why?
|
| Terminology as Topic | 1 | 2020 | 145 | 0.600 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 2018 | 17 | 0.600 |
Why?
|
| Sexual Behavior, Animal | 6 | 2002 | 88 | 0.550 |
Why?
|
| Receptors, Cell Surface | 6 | 2000 | 432 | 0.500 |
Why?
|
| Vasopressins | 3 | 2019 | 15 | 0.500 |
Why?
|
| Testosterone | 10 | 2004 | 128 | 0.490 |
Why?
|
| Arginine Vasopressin | 5 | 2019 | 20 | 0.480 |
Why?
|
| Trans-Activators | 2 | 2008 | 321 | 0.480 |
Why?
|
| Gene Expression | 6 | 2011 | 854 | 0.470 |
Why?
|
| Tretinoin | 1 | 2015 | 49 | 0.460 |
Why?
|
| Receptors, Androgen | 3 | 2004 | 88 | 0.450 |
Why?
|
| Reproduction | 12 | 2003 | 100 | 0.430 |
Why?
|
| Brain | 11 | 2022 | 1625 | 0.420 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2000 | 151 | 0.410 |
Why?
|
| Receptors, Estrogen | 4 | 1999 | 132 | 0.400 |
Why?
|
| Animals, Laboratory | 1 | 2013 | 6 | 0.400 |
Why?
|
| Animal Husbandry | 1 | 2013 | 10 | 0.400 |
Why?
|
| Seasons | 14 | 1999 | 140 | 0.390 |
Why?
|
| Arousal | 1 | 2013 | 42 | 0.390 |
Why?
|
| Neuropeptides | 6 | 2013 | 81 | 0.370 |
Why?
|
| In Situ Hybridization | 6 | 2022 | 213 | 0.370 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 159 | 0.360 |
Why?
|
| Nuclear Proteins | 4 | 2006 | 792 | 0.360 |
Why?
|
| Neurosecretory Systems | 5 | 2003 | 24 | 0.360 |
Why?
|
| RNA, Messenger | 10 | 2008 | 1580 | 0.360 |
Why?
|
| Neural Pathways | 3 | 2010 | 103 | 0.340 |
Why?
|
| Photic Stimulation | 4 | 2018 | 89 | 0.340 |
Why?
|
| Immunohistochemistry | 8 | 2018 | 898 | 0.330 |
Why?
|
| Transcription Factors | 6 | 2022 | 1559 | 0.330 |
Why?
|
| Male | 50 | 2018 | 31292 | 0.330 |
Why?
|
| Androgens | 5 | 2004 | 67 | 0.320 |
Why?
|
| Gonadotropin-Releasing Hormone | 5 | 2019 | 88 | 0.300 |
Why?
|
| Receptors, Vasopressin | 1 | 2008 | 1 | 0.290 |
Why?
|
| Bromodeoxyuridine | 3 | 2023 | 44 | 0.270 |
Why?
|
| Heterozygote | 3 | 2012 | 173 | 0.250 |
Why?
|
| Olfactory Bulb | 2 | 2002 | 19 | 0.250 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 5 | 1991 | 19 | 0.250 |
Why?
|
| Mice | 7 | 2022 | 11173 | 0.240 |
Why?
|
| Sheep | 15 | 1993 | 194 | 0.240 |
Why?
|
| Pituitary Gland, Anterior | 3 | 1992 | 30 | 0.240 |
Why?
|
| Phodopus | 7 | 2004 | 9 | 0.230 |
Why?
|
| Prolactin | 9 | 2003 | 40 | 0.210 |
Why?
|
| Estradiol | 13 | 1999 | 260 | 0.210 |
Why?
|
| Endocrine Glands | 2 | 2003 | 7 | 0.210 |
Why?
|
| Pituitary Gland | 6 | 1996 | 50 | 0.200 |
Why?
|
| Brain Tissue Transplantation | 2 | 1996 | 4 | 0.200 |
Why?
|
| Animal Care Committees | 2 | 2013 | 8 | 0.200 |
Why?
|
| Female | 37 | 2023 | 34309 | 0.200 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 2 | 2004 | 18 | 0.200 |
Why?
|
| Seminiferous Tubules | 1 | 2003 | 2 | 0.200 |
Why?
|
| Prosencephalon | 1 | 2003 | 37 | 0.190 |
Why?
|
| Time Factors | 12 | 2015 | 3777 | 0.190 |
Why?
|
| Castration | 11 | 2003 | 43 | 0.190 |
Why?
|
| Hepatitis | 20 | 1985 | 58 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2018 | 52 | 0.190 |
Why?
|
| Estrous Cycle | 1 | 2002 | 12 | 0.180 |
Why?
|
| Neurogenesis | 1 | 2023 | 64 | 0.180 |
Why?
|
| Gene Expression Regulation | 4 | 2010 | 1633 | 0.180 |
Why?
|
| Analysis of Variance | 4 | 2014 | 606 | 0.180 |
Why?
|
| Liver | 12 | 2010 | 874 | 0.180 |
Why?
|
| Body Weight | 8 | 2004 | 377 | 0.160 |
Why?
|
| Mammals | 1 | 2022 | 222 | 0.160 |
Why?
|
| Follicle Stimulating Hormone | 5 | 2003 | 86 | 0.160 |
Why?
|
| Kisspeptins | 1 | 2019 | 26 | 0.150 |
Why?
|
| Lighting | 3 | 2003 | 14 | 0.150 |
Why?
|
| Organ Size | 8 | 1998 | 174 | 0.150 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1999 | 7 | 0.150 |
Why?
|
| Genes, fos | 1 | 2018 | 18 | 0.140 |
Why?
|
| Receptors, Melatonin | 5 | 2000 | 34 | 0.140 |
Why?
|
| Hormones | 2 | 2015 | 62 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 3500 | 0.140 |
Why?
|
| Kidney | 3 | 2006 | 458 | 0.140 |
Why?
|
| Lampreys | 1 | 1998 | 6 | 0.140 |
Why?
|
| Infant, Newborn | 1 | 2023 | 1437 | 0.140 |
Why?
|
| CLOCK Proteins | 2 | 2008 | 46 | 0.140 |
Why?
|
| Fishes | 1 | 1998 | 23 | 0.140 |
Why?
|
| Receptors, Opioid | 2 | 1995 | 15 | 0.130 |
Why?
|
| Humans | 44 | 2023 | 65645 | 0.130 |
Why?
|
| Estrus | 8 | 1999 | 26 | 0.130 |
Why?
|
| Radioimmunoassay | 5 | 1997 | 63 | 0.130 |
Why?
|
| Gastrointestinal Hormones | 2 | 2008 | 10 | 0.130 |
Why?
|
| Neuroendocrinology | 1 | 2016 | 2 | 0.120 |
Why?
|
| Connectome | 1 | 2016 | 38 | 0.120 |
Why?
|
| Sertoli Cells | 1 | 2015 | 13 | 0.120 |
Why?
|
| Leydig Cells | 1 | 2015 | 12 | 0.120 |
Why?
|
| Copulation | 1 | 1995 | 17 | 0.120 |
Why?
|
| Liver Cirrhosis | 19 | 1986 | 184 | 0.110 |
Why?
|
| Neural Inhibition | 1 | 1995 | 30 | 0.110 |
Why?
|
| Spermatogenesis | 1 | 2015 | 76 | 0.110 |
Why?
|
| Fetal Tissue Transplantation | 2 | 1996 | 12 | 0.110 |
Why?
|
| Orchiectomy | 3 | 2004 | 40 | 0.110 |
Why?
|
| Sciuridae | 1 | 1994 | 3 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 909 | 0.110 |
Why?
|
| Methadone | 1 | 1995 | 140 | 0.110 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2014 | 51 | 0.100 |
Why?
|
| Steroids | 1 | 1994 | 56 | 0.100 |
Why?
|
| Naloxone | 2 | 1994 | 53 | 0.100 |
Why?
|
| Orexins | 1 | 2013 | 6 | 0.100 |
Why?
|
| Cell Cycle Proteins | 3 | 2006 | 404 | 0.100 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2013 | 35 | 0.100 |
Why?
|
| Locus Coeruleus | 1 | 2013 | 24 | 0.100 |
Why?
|
| Brain Diseases | 2 | 1991 | 76 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2010 | 788 | 0.090 |
Why?
|
| Receptors, Progesterone | 2 | 1990 | 112 | 0.090 |
Why?
|
| Advisory Committees | 1 | 2013 | 111 | 0.090 |
Why?
|
| Species Specificity | 4 | 1999 | 344 | 0.090 |
Why?
|
| Homozygote | 1 | 2012 | 122 | 0.090 |
Why?
|
| Genotype | 1 | 2014 | 674 | 0.090 |
Why?
|
| Reticular Formation | 7 | 1969 | 9 | 0.090 |
Why?
|
| Locomotion | 2 | 2012 | 111 | 0.090 |
Why?
|
| Casein Kinase Idelta | 1 | 2011 | 7 | 0.090 |
Why?
|
| Crosses, Genetic | 1 | 2011 | 116 | 0.090 |
Why?
|
| Liver Diseases | 12 | 1983 | 157 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 345 | 0.080 |
Why?
|
| DNA Primers | 1 | 2011 | 301 | 0.080 |
Why?
|
| Alleles | 1 | 2012 | 455 | 0.080 |
Why?
|
| Antimetabolites | 2 | 2002 | 18 | 0.080 |
Why?
|
| Pituitary Hormones | 1 | 1990 | 7 | 0.080 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 2 | 1989 | 3 | 0.080 |
Why?
|
| Ovariectomy | 5 | 1992 | 104 | 0.080 |
Why?
|
| Immunosuppressive Agents | 7 | 1982 | 381 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1389 | 0.080 |
Why?
|
| Endorphins | 1 | 1989 | 12 | 0.080 |
Why?
|
| Base Sequence | 2 | 2011 | 1331 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2010 | 200 | 0.080 |
Why?
|
| Preoptic Area | 2 | 2004 | 49 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2004 | 152 | 0.070 |
Why?
|
| Brain Chemistry | 3 | 1994 | 76 | 0.070 |
Why?
|
| Amygdala | 2 | 2004 | 85 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2004 | 292 | 0.070 |
Why?
|
| Cell Nucleus | 3 | 1990 | 634 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 542 | 0.070 |
Why?
|
| Prednisone | 10 | 1985 | 83 | 0.060 |
Why?
|
| Adrenal Medulla | 1 | 2006 | 7 | 0.060 |
Why?
|
| Tissue Transplantation | 1 | 2006 | 9 | 0.060 |
Why?
|
| ARNTL Transcription Factors | 1 | 2006 | 25 | 0.060 |
Why?
|
| Pregnancy | 9 | 1996 | 2393 | 0.060 |
Why?
|
| Limbic System | 3 | 1995 | 27 | 0.060 |
Why?
|
| Azathioprine | 8 | 1985 | 27 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 158 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 312 | 0.060 |
Why?
|
| Parabiosis | 1 | 2005 | 3 | 0.060 |
Why?
|
| Lung | 1 | 2010 | 969 | 0.060 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2004 | 6 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2007 | 963 | 0.050 |
Why?
|
| Homeostasis | 1 | 2007 | 383 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 59 | 0.050 |
Why?
|
| Oscillometry | 1 | 2004 | 12 | 0.050 |
Why?
|
| Heart | 1 | 2006 | 298 | 0.050 |
Why?
|
| Septal Nuclei | 1 | 2004 | 54 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 96 | 0.050 |
Why?
|
| Hypothalamus, Middle | 2 | 1996 | 20 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 385 | 0.050 |
Why?
|
| Hypothalamus | 6 | 1984 | 135 | 0.050 |
Why?
|
| Adrenalectomy | 2 | 1979 | 26 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2002 | 233 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 672 | 0.050 |
Why?
|
| Odorants | 1 | 2002 | 19 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2022 | 23 | 0.050 |
Why?
|
| Neuropeptide Y | 1 | 2001 | 13 | 0.040 |
Why?
|
| Darkness | 4 | 1987 | 20 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 869 | 0.040 |
Why?
|
| Chronic Disease | 21 | 1985 | 744 | 0.040 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1981 | 2 | 0.040 |
Why?
|
| Neural Conduction | 1 | 1981 | 32 | 0.040 |
Why?
|
| Adrenal Glands | 2 | 1979 | 36 | 0.040 |
Why?
|
| Cell Division | 1 | 2002 | 450 | 0.040 |
Why?
|
| Cell Movement | 1 | 2002 | 482 | 0.040 |
Why?
|
| Colchicine | 3 | 1986 | 29 | 0.040 |
Why?
|
| Optic Chiasm | 1 | 1979 | 6 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 1999 | 49 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 1979 | 0.040 |
Why?
|
| Glucocorticoids | 2 | 1999 | 190 | 0.040 |
Why?
|
| Histocytochemistry | 4 | 1987 | 48 | 0.040 |
Why?
|
| Dentate Gyrus | 1 | 1998 | 12 | 0.040 |
Why?
|
| Ganglia, Sympathetic | 2 | 1989 | 5 | 0.040 |
Why?
|
| Hagfishes | 1 | 1998 | 1 | 0.030 |
Why?
|
| Neuroglia | 1 | 1998 | 81 | 0.030 |
Why?
|
| Iodine Radioisotopes | 2 | 1996 | 60 | 0.030 |
Why?
|
| Secretory Rate | 2 | 1995 | 10 | 0.030 |
Why?
|
| Linear Models | 1 | 1998 | 405 | 0.030 |
Why?
|
| Triazolam | 1 | 1996 | 4 | 0.030 |
Why?
|
| Time | 1 | 1996 | 30 | 0.030 |
Why?
|
| Proteins | 6 | 1973 | 764 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 1995 | 15 | 0.030 |
Why?
|
| Efferent Pathways | 1 | 1995 | 9 | 0.030 |
Why?
|
| Binding Sites | 3 | 1996 | 917 | 0.030 |
Why?
|
| Reference Values | 1 | 1996 | 328 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 1996 | 127 | 0.030 |
Why?
|
| Feedback | 4 | 1984 | 91 | 0.030 |
Why?
|
| Social Environment | 1 | 1995 | 93 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2016 | 180 | 0.030 |
Why?
|
| Autonomic Nervous System | 2 | 1966 | 35 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1994 | 86 | 0.030 |
Why?
|
| Hepatitis B Antigens | 3 | 1981 | 4 | 0.030 |
Why?
|
| Sulfatases | 1 | 1974 | 7 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 858 | 0.020 |
Why?
|
| Retina | 3 | 1995 | 135 | 0.020 |
Why?
|
| Ovary | 3 | 1984 | 105 | 0.020 |
Why?
|
| Research | 2 | 1965 | 195 | 0.020 |
Why?
|
| Autoradiography | 2 | 1990 | 52 | 0.020 |
Why?
|
| Reflex | 3 | 1966 | 27 | 0.020 |
Why?
|
| beta-Endorphin | 1 | 1991 | 9 | 0.020 |
Why?
|
| Lymphocyte Activation | 6 | 1985 | 754 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1991 | 70 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 1990 | 23 | 0.020 |
Why?
|
| Promegestone | 1 | 1990 | 11 | 0.020 |
Why?
|
| Progestins | 1 | 1990 | 29 | 0.020 |
Why?
|
| gamma-Globulins | 3 | 1982 | 10 | 0.020 |
Why?
|
| Seminal Vesicles | 1 | 1989 | 8 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 1989 | 21 | 0.020 |
Why?
|
| Progesterone | 4 | 1984 | 165 | 0.020 |
Why?
|
| Blood Pressure | 2 | 1963 | 535 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 1969 | 139 | 0.020 |
Why?
|
| Pressoreceptors | 2 | 1966 | 4 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 1969 | 7 | 0.020 |
Why?
|
| Estrogens | 1 | 1989 | 115 | 0.020 |
Why?
|
| Cytosol | 1 | 1990 | 183 | 0.020 |
Why?
|
| Cerebral Cortex | 2 | 1969 | 270 | 0.020 |
Why?
|
| Autoantibodies | 4 | 1982 | 185 | 0.020 |
Why?
|
| Hepatitis, Viral, Human | 2 | 1978 | 12 | 0.020 |
Why?
|
| Postgastrectomy Syndromes | 2 | 1965 | 4 | 0.020 |
Why?
|
| Metribolone | 1 | 1988 | 3 | 0.020 |
Why?
|
| Thalamus | 1 | 1969 | 78 | 0.020 |
Why?
|
| Estrenes | 1 | 1988 | 9 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 1987 | 30 | 0.020 |
Why?
|
| Hepatitis, Chronic | 2 | 1985 | 6 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1987 | 9 | 0.020 |
Why?
|
| Hepatitis A | 2 | 1964 | 7 | 0.020 |
Why?
|
| Functional Laterality | 1 | 1987 | 140 | 0.020 |
Why?
|
| Mitogens | 2 | 1985 | 10 | 0.020 |
Why?
|
| Hydroxyproline | 2 | 1986 | 6 | 0.020 |
Why?
|
| Hippocampus | 1 | 1969 | 277 | 0.020 |
Why?
|
| Lactose Intolerance | 3 | 1971 | 4 | 0.020 |
Why?
|
| Liver Regeneration | 5 | 1974 | 20 | 0.020 |
Why?
|
| Cats | 5 | 1969 | 92 | 0.020 |
Why?
|
| Mesencephalon | 1 | 1966 | 28 | 0.010 |
Why?
|
| Anabolic Agents | 3 | 1971 | 8 | 0.010 |
Why?
|
| Models, Biological | 3 | 1984 | 1193 | 0.010 |
Why?
|
| Gallamine Triethiodide | 1 | 1965 | 1 | 0.010 |
Why?
|
| Protein-Losing Enteropathies | 1 | 1965 | 1 | 0.010 |
Why?
|
| Midbrain Reticular Formation | 1 | 1965 | 1 | 0.010 |
Why?
|
| Tubocurarine | 1 | 1965 | 2 | 0.010 |
Why?
|
| Pharmacology | 1 | 1965 | 4 | 0.010 |
Why?
|
| Flavoproteins | 1 | 2005 | 28 | 0.010 |
Why?
|
| Parasympathetic Nervous System | 1 | 1965 | 6 | 0.010 |
Why?
|
| Neurophysiology | 1 | 1965 | 7 | 0.010 |
Why?
|
| Brain Stem | 1 | 1965 | 30 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1965 | 35 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1965 | 32 | 0.010 |
Why?
|
| Paternal Behavior | 1 | 1984 | 6 | 0.010 |
Why?
|
| Columbidae | 1 | 1984 | 15 | 0.010 |
Why?
|
| Gonads | 1 | 1984 | 18 | 0.010 |
Why?
|
| Proestrus | 1 | 1983 | 4 | 0.010 |
Why?
|
| Maternal Behavior | 1 | 1984 | 31 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 1984 | 86 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1993 | 3162 | 0.010 |
Why?
|
| Rats | 3 | 1984 | 1996 | 0.010 |
Why?
|
| Anestrus | 1 | 1982 | 1 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1963 | 89 | 0.010 |
Why?
|
| Serum Globulins | 1 | 1982 | 1 | 0.010 |
Why?
|
| Immunoelectrophoresis | 1 | 1982 | 2 | 0.010 |
Why?
|
| United States | 1 | 2016 | 8166 | 0.010 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2001 | 2 | 0.010 |
Why?
|
| Vasomotor System | 1 | 1962 | 23 | 0.010 |
Why?
|
| Antibody Formation | 2 | 1983 | 111 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 1982 | 186 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2005 | 1291 | 0.010 |
Why?
|
| Dogs | 5 | 1966 | 324 | 0.010 |
Why?
|
| Hepatitis B e Antigens | 1 | 1981 | 2 | 0.010 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1981 | 18 | 0.010 |
Why?
|
| Nervous System | 1 | 1981 | 71 | 0.010 |
Why?
|
| Colonic Diseases, Functional | 2 | 1970 | 3 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1982 | 239 | 0.010 |
Why?
|
| Hypophysectomy | 1 | 1980 | 2 | 0.010 |
Why?
|
| Activity Cycles | 1 | 1980 | 2 | 0.010 |
Why?
|
| Intestinal Diseases | 2 | 1971 | 38 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1983 | 565 | 0.010 |
Why?
|
| Immunity, Cellular | 2 | 1977 | 170 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2001 | 418 | 0.010 |
Why?
|
| Fatty Liver | 2 | 1974 | 115 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1979 | 14 | 0.010 |
Why?
|
| Environment, Controlled | 1 | 1978 | 3 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1983 | 1010 | 0.010 |
Why?
|
| Liver Function Tests | 4 | 1986 | 38 | 0.010 |
Why?
|
| Immunoglobulins | 4 | 1979 | 74 | 0.010 |
Why?
|
| Obesity | 1 | 1985 | 1277 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1979 | 308 | 0.010 |
Why?
|
| Nucleoproteins | 2 | 1973 | 32 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 1995 | 16 | 0.010 |
Why?
|
| Visual Pathways | 1 | 1995 | 21 | 0.010 |
Why?
|
| Serum Albumin | 2 | 1972 | 47 | 0.010 |
Why?
|
| Jejunum | 2 | 1971 | 15 | 0.010 |
Why?
|
| Hospitals, State | 1 | 1954 | 9 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1974 | 67 | 0.010 |
Why?
|
| Injections | 1 | 1993 | 84 | 0.010 |
Why?
|
| Rheumatic Diseases | 1 | 1954 | 42 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 1954 | 41 | 0.010 |
Why?
|
| Thymol | 1 | 1972 | 4 | 0.010 |
Why?
|
| Blood Proteins | 4 | 1974 | 84 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1972 | 35 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1972 | 46 | 0.010 |
Why?
|
| Adult | 8 | 1986 | 17511 | 0.010 |
Why?
|
| Duodenal Obstruction | 1 | 1971 | 5 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 1971 | 15 | 0.010 |
Why?
|
| Leiomyoma | 1 | 1971 | 18 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1970 | 20 | 0.000 |
Why?
|
| Androstanes | 1 | 1969 | 1 | 0.000 |
Why?
|
| 17-Hydroxycorticosteroids | 1 | 1969 | 1 | 0.000 |
Why?
|
| Dinitrochlorobenzene | 2 | 1977 | 3 | 0.000 |
Why?
|
| Carotid Sinus | 1 | 1966 | 1 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1954 | 872 | 0.000 |
Why?
|
| Biopsy | 1 | 1967 | 460 | 0.000 |
Why?
|
| Hyperplasia | 1 | 1965 | 91 | 0.000 |
Why?
|
| Prognosis | 2 | 1981 | 1791 | 0.000 |
Why?
|
| Iodine Isotopes | 1 | 1964 | 2 | 0.000 |
Why?
|
| Povidone-Iodine | 1 | 1964 | 5 | 0.000 |
Why?
|
| Povidone | 1 | 1964 | 8 | 0.000 |
Why?
|
| Radiometry | 1 | 1964 | 39 | 0.000 |
Why?
|
| Dietary Fats | 1 | 1985 | 181 | 0.000 |
Why?
|
| Photoreceptor Cells | 1 | 1984 | 18 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1985 | 240 | 0.000 |
Why?
|
| Blindness | 1 | 1984 | 43 | 0.000 |
Why?
|
| Feces | 1 | 1964 | 118 | 0.000 |
Why?
|
| Sexual Maturation | 1 | 1984 | 53 | 0.000 |
Why?
|
| Regeneration | 1 | 1965 | 126 | 0.000 |
Why?
|
| Pokeweed Mitogens | 1 | 1983 | 3 | 0.000 |
Why?
|
| Concanavalin A | 1 | 1983 | 40 | 0.000 |
Why?
|
| Lipoproteins | 2 | 1974 | 85 | 0.000 |
Why?
|
| Methods | 1 | 1982 | 40 | 0.000 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1983 | 22 | 0.000 |
Why?
|
| Lectins | 1 | 1983 | 43 | 0.000 |
Why?
|
| Skull | 1 | 1982 | 52 | 0.000 |
Why?
|
| Middle Aged | 4 | 1986 | 18439 | 0.000 |
Why?
|
| Collagen | 1 | 1983 | 135 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1981 | 142 | 0.000 |
Why?
|
| Trinitrotoluene | 1 | 1961 | 1 | 0.000 |
Why?
|
| Physiological Phenomena | 1 | 1961 | 2 | 0.000 |
Why?
|
| Chemical Industry | 1 | 1961 | 8 | 0.000 |
Why?
|
| Nitro Compounds | 1 | 1961 | 15 | 0.000 |
Why?
|
| Hematologic Diseases | 1 | 1961 | 12 | 0.000 |
Why?
|
| Neuromuscular Junction | 1 | 1961 | 83 | 0.000 |
Why?
|
| Metabolic Diseases | 1 | 1961 | 59 | 0.000 |
Why?
|
| Diarrhea | 2 | 1971 | 73 | 0.000 |
Why?
|
| Kinetics | 1 | 1981 | 757 | 0.000 |
Why?
|
| Aged | 3 | 1986 | 15089 | 0.000 |
Why?
|
| Recurrence | 1 | 1981 | 664 | 0.000 |
Why?
|
| Hydroxyzine | 1 | 1959 | 2 | 0.000 |
Why?
|
| Tranquilizing Agents | 1 | 1959 | 2 | 0.000 |
Why?
|
| Radiography | 2 | 1971 | 558 | 0.000 |
Why?
|
| Occupational Diseases | 1 | 1961 | 266 | 0.000 |
Why?
|
| Skin Tests | 1 | 1977 | 18 | 0.000 |
Why?
|
| Mitochondria, Liver | 1 | 1977 | 13 | 0.000 |
Why?
|
| Antibodies, Antinuclear | 1 | 1977 | 41 | 0.000 |
Why?
|
| Plasma Cells | 1 | 1977 | 52 | 0.000 |
Why?
|
| Counterimmunoelectrophoresis | 1 | 1977 | 1 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1977 | 5 | 0.000 |
Why?
|
| Tuberculin Test | 1 | 1977 | 9 | 0.000 |
Why?
|
| Antibody-Producing Cells | 1 | 1977 | 12 | 0.000 |
Why?
|
| Nerve Endings | 1 | 1956 | 8 | 0.000 |
Why?
|
| Muscle, Smooth | 1 | 1977 | 135 | 0.000 |
Why?
|
| Atropine | 1 | 1956 | 13 | 0.000 |
Why?
|
| Acute Disease | 1 | 1978 | 663 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1977 | 254 | 0.000 |
Why?
|
| Hepatitis B | 1 | 1976 | 28 | 0.000 |
Why?
|
| Immunity | 1 | 1977 | 107 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1981 | 2496 | 0.000 |
Why?
|
| Prothrombin | 1 | 1974 | 4 | 0.000 |
Why?
|
| Drug Tolerance | 1 | 1974 | 33 | 0.000 |
Why?
|
| Phosphorus | 1 | 1973 | 16 | 0.000 |
Why?
|
| Transaminases | 1 | 1973 | 15 | 0.000 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1973 | 45 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1974 | 463 | 0.000 |
Why?
|
| Liver Extracts | 1 | 1971 | 1 | 0.000 |
Why?
|
| Diet Therapy | 1 | 1971 | 15 | 0.000 |
Why?
|
| Nucleic Acids | 1 | 1973 | 67 | 0.000 |
Why?
|
| Vitamins | 1 | 1971 | 80 | 0.000 |
Why?
|
| Galactosidases | 1 | 1971 | 2 | 0.000 |
Why?
|
| Monosaccharides | 1 | 1971 | 7 | 0.000 |
Why?
|
| Ileum | 1 | 1970 | 21 | 0.000 |
Why?
|
| Prothrombin Time | 1 | 1969 | 6 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1970 | 502 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1968 | 129 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1969 | 333 | 0.000 |
Why?
|